HBV and HIV screening, and hepatitis B immunization programme in the prison of Marseille, France

International Journal of STD and AIDS

Volumn 8, Issue 12, 1997, Pages 753-759

  Rotily, M ^a,b   Vernay Vaisse, C ^c   Bourliere M ^d   Galinier Pujol, A ^e   Rousseau, S ^f   Obadia, Y ^a,b  

^a OBSERVATOIRE RÉGIONAL DE LA SANTÉ PROVENCE ALPES CÔTE D AZUR   (France)

^b INSERM   (France)

^c DISS   (France)

^d HÔPITAL SAINT JOSEPH   (France)

^e Ctr Penitentiaire de Marseille   (France)

^f Lab Departemental de S Pub   (France)

Author keywords

France; Hepatitis B; Immunization; Prisons; Screening

Indexed keywords

HEPATITIS B VACCINE; MARKER;

ADULT; ARTICLE; CLINICAL TRIAL; DRUG ABUSE; EDUCATION; FEMALE; FRANCE; HEPATITIS B; HEPATITIS B VIRUS; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PRISON; SCREENING; SEROLOGY; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SYPHILIS;

ADOLESCENT; ADULT; COMPLIANCE; FEMALE; FRANCE; HEPATITIS B; HIV INFECTIONS; HUMANS; MALE; MASS SCREENING; PREVALENCE; PRISONS; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS; VACCINATION;

EID: 0030733884     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462971919228     Document Type: Article

References (29)

1. Rotily M, Galinier-Pujol A, Vernay-Vaisse C. Risk behaviors of inmates in southeastern France. AIDS Care 1995;7(suppl 1):91-5
2. Bird AG, Gore SM, Jolliffe DW, Burns SM. Anonymous HIV surveillance in Saughton Prison, Edinburgh. AIDS 1992;6:725-33
3. Rotily M, Galinier-Pujol A, Obadia Y, et al. HIV infection and associated risk factors among inmates in southeastern French prisons. AIDS 1994;8:1341-4
4. Espinoza P, Bouchard I, Buffet C, Thiers V, Pillot J, Etienne JP. Forte prévalence de l'infection par le virus de l'hépatite B et le virus VIH chez les toxicomanes français incarcérés. Gastroenterol Clin Biol 1987;11:288-92
5. Bayas JM, Bruguera M, Martin V, Vidai J, Rodes J, Salleras LY. Hepatitis B vaccination in prisons: the Catalonian experience. Vaccine 1993;11(14):1441-4
6. Chiaramonte M, Trivello R, Renzulli G, et al. Hepatitis B virus infection in prisons: a seroepidemiological survey in prisoners and attending staff. J Hyg Camb 1982;89:53-8
7. Goudeau A, Dubois F. Incidence and prevalence of hepatitis B in France. Vaccine 1995;13(suppl 1):S22-S25
8. Anda RF, Perlman SN, d'Alassio DJ, Davies JP, Dodson VN. Hepatitis B in Wisconsin male prisoners: considerations for serological screening and vaccination. Am J Public Health 1985;75:1182-5
9. Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996;86:655-61
10. Bourdillon F, Bonnevie MC, Martinez R, Enquête un jour donné, en milieu pénitentiaire, sur l'infection par le VIH. Principaux résultats. Ministère des Affaires Sociales, de la Santé et de la Ville, Direction des Hôpitaux-Mission Sida, Ministère de la Justice-Direction de l'Administration Pénitentiaire, 1995
11. Anonymous. L'infection àVIH en France: tendances actuelles-Journée mondiale du Sida du 1 décembre 1996. Réseau National de Santé Publique, Parts, 1996
12. Six C, Hamers F, Ancelle-Park R, Brunet JB and correspondents of the Rehabilitation Centres. XI International Conference on AIDS, Vancouver, British Columbia, Tu.C.2507, 1996
13. Ingold FR, Toussirt M. Transmission of HIV among drug addicts in three French cities: implications for prevention. Bull Narc 1993;45(1):117-34
14. Marsano LS, Greenberg RN, Kirkpatrick RB, et al. Comparison of a rapid hepatitis B immunization schedule to the standard schedule for adults. Am J Gastroenterol 1996;91(1):111-15
15. Margolis HS, Presson AC. Host factors related to poor immunogenicity of hepatitis B vaccine in adults. Another reason to immunize early. JAMA 1993;270(24):2971-2
16. Haut Comité de Santé Publique. Santé en Milieu Caréral. Collection Avis et Rapports du HCSP, ENSP Editeurs, Rennes, 1993
17. McKee KJ, Markova I, Power KG. Concern, preceived risk and attitudes towards HIV/AIDS in Scottish prisons. AIDS Care 1995;7(2):159-70
18. Sterner G, Agell BO, Gerzen P, Berg R. Hepatitis with Australian antigen after tattooing. Scand J Infect Dis 1971;3:109-12
19. Rotily M, Gore SM, Weilandt C. Heterosexual intercourse in prison (submitted).
20. Gore SM, Bird AG, Hutchinson S. Injection inmates and anal sex with another man in prison (submitted)
21. Bird AG, Gore SM, Cameron S, Ross AJ, Goldberg DJ. Anonymous HIV surveillance with risk factor elicitation at Scotland's largest prison, Barlinnie. AIDS 1995;9(7):801-8
22. Holsen DS, Harthug S, Myrmel H. Prevalence of antibodies to hepatitis C virus and association with intravenous drug abuse and tattooing in a national prison in Norway. Eur J Clin Microbiol Infect Dis 1993;12(9):673-6
23. Taylor A, Goldberg DJ, Emslie J, et al. Outbreak of HIV infection in a Scottish prison. BMJ 1995;310:289-92
24. Margolis HS, Coleman PJ, Brown RE, Mast EE, Sheingold SH, Arevalo JA. Prevention of hepatitis B virus transmission by immunization: an economic analysis of current recommendations. JAMA 1995;274:1201-8
25. Mangtani P, Hall AJ, Normand CEM. Hepatitis B vaccination: the cost effectiveness of alternative strategies in England and Wales. J Epidemiol Comm Health 1995;49:238-44
26. Anonymous. Hépatites virales: dépistage, prévention, traitement, Collection Expertises Collectives, Editions INSERM (1997), Paris
27. Rotily M, Moatti JP, Janvrin MP, Baudier F, Grillo B, Raoult D. Opinions et pratiques des médecins généralistes français face àla vaccination contre l'hépatite B. Med Mal Infect 1996;26(4):496-503
28. Watters JK, Kral AH. Cost-effectiveness of hepatitis B virus immunization [Letter]. JAMA 1996;275(12):907-8
29. Francis DP. The public's health unprotected: reversing a decade of underutilization of hepatitis B vaccine. JAMA 1995;274:1242-3